$50.33Average Price Target
The highest estimate is 60.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
FAQs
What is Apnimed stock price today?▼
The current price of APMD is $16.40 USD — it has decreased by -5.42% in the past 24 hours. Watch Apnimed stock price performance more closely on the chart.
What is Apnimed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Apnimed stocks are traded under the ticker APMD.
What is Apnimed market cap?▼
Today Apnimed has the market capitalization of 682.74M
When is the next Apnimed earnings date?▼
Apnimed is going to release the next earnings report on December 2, 2026.
What were Apnimed earnings last quarter?▼
APMD earnings for the last quarter are 3.92 USD per share, whereas the estimation was -0.49 USD resulting in a +905.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Apnimed revenue for the last year?▼
Apnimed revenue for the last year amounts to 38.47M USD.
What is Apnimed net income for the last year?▼
APMD net income for the last year is -128.19M USD.
How many employees does Apnimed have?▼
As of November 1, 2026, the company has 65 employees.
In which sector is Apnimed located?▼
Apnimed operates in the Health & Wellness sector.
When did Apnimed complete a stock split?▼
Apnimed has not had any recent stock splits.
Where is Apnimed headquartered?▼
Apnimed is headquartered in CAMBRIDGE, United States.